FDA OKs Avastin for Advanced Breast Cancer
FRIDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug
Administration on Friday approved the cancer drug Avastin for women
with advanced breast cancer, going against the recommendation of
its own advisory panel.